PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsTakeda
Takeda(TAK)
The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Actoplus metMetformin, Pioglitazone2005-08-292023-2035
ActosPioglitazone1999-07-152023-2029
AdcetrisBrentuximab vedotin2012-10-25
AdderallAmphetamine, Amphetamine aspartate, Dextroamphetamine, Dextroamphetamine saccharate2001-10-112024-2038
AdvateOctocog alfa, Albumin free method, Antihemophilic factor (recombinant), plasma2004-03-02
AgrylinAnagrelide1997-03-14
AlofiselDarvadstrocel2018-03-23
AlunbrigBrigatinib2017-04-282029-2035
CarbatrolCarbamazepine1997-09-302024-2040
CeradonCefotiam1988-12-30
1
2
3
4
5
6
...
8
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bortezomib
Ixazomib
1
2
3
4
5
6
...
18
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use